Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting
Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...
Woman who had 'cold she couldn't shake' told she had less than a year to live
Nicola Heart, 37, was diagnosed with metastatic breast cancer after years of debilitating symptoms and given just months to ...
Woman mistook symptoms for common cold before being told she has year to live
Nicola Heart, from New York, US, was diagnosed with incurable breast cancer after doctors discovered the disease had spread ...
Woman who had 'cold she couldn't shake' told she had year to live
A 37-year old woman was told she had less than a year to live after doctors said she had incurable breast cancer. Nicola ...
Targeted Oncology2d
Barriers Considered When Treating Patients With Bladder Cancer
The first barrier Grivas notes is limited infusion room capacity and the need for rapid chair turnover. Other external barriers for patients include transportation and lodging. Grivas highlights that ...
BioArctic's partner Eisai presents sales simulation for Leqembi at its annual press conference
BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for ...
Stage 4 cancer and given a year to live... but more alive than ever
Nicola Heart believed that holding her newborn babies as they died would be the most difficult experience of her life. That ...
Fierce Biotech6d
Eisai's abandoned Enhertu challenger set to live on at BlissBio
BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...
The Citizen6d
Alberton mom needs help to afford life-saving cancer treatment
Tanya de Bruin and her father were diagnosed with cancer just a week apart, fighting the disease together. Now, after losing ...